申请人:NEKTAR THERAPEUTICS
公开号:US20150065706A1
公开(公告)日:2015-03-05
The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
本发明涉及包括给予含寡聚物的取代芳基三嗪化合物的方法在内的治疗方法。本发明的化合物在通过任何一种给药途径给予时,相对于缺乏寡聚物的相应化合物,表现出一种或多种优点。